Literature DB >> 7624279

Special considerations in the use of glucocorticoids in children.

J D Spahn1, A K Kamada.   

Abstract

GCs are used commonly for the treatment of various inflammatory and autoimmune diseases. Although potent and generally effective, they are not without risks for producing serious adverse effects, especially when used in high doses for prolonged periods of time. Thus, the clinician must balance the therapeutic effects of GCs with their risks for adverse effects; using the lowest possible effective GC doses as well as maximizing other therapeutic modalities are means by which this goal can be achieved. Early recognition and appropriate management are other methods to minimize GC-induced adverse effects. Maximization of therapy, early recognition, and appropriate management of adverse effects can minimize the potential severe complications of GC therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624279     DOI: 10.1542/pir.16-7-266

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  6 in total

Review 1.  Pharmacotherapy of lupus nephritis in children: a recommended treatment approach.

Authors:  Alexa Adams; Emma Jane MacDermott; Thomas J A Lehman
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Anesthetic and dental management of a child with IMAGe syndrome.

Authors:  Rochelle G Lindemeyer; Stephanie E Rashewsky; Phillip J Louie; Laura Schleelein
Journal:  Anesth Prog       Date:  2014

Review 3.  Systemic corticosteroid therapy--side effects and their management.

Authors:  R M Stanbury; E M Graham
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

Review 4.  Glucocorticoids in the management of systemic juvenile idiopathic arthritis.

Authors:  Gaia Vannucci; Luca Cantarini; Teresa Giani; Edoardo Marrani; Davide Moretti; Ilaria Pagnini; Gabriele Simonini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

5.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25

6.  Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data.

Authors:  Rosemary G Peterson; Rui Xiao; Hannah Katcoff; Brian T Fisher; Pamela F Weiss
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-05       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.